MedTrace Logo

Post Marketing Surveillance Of Fesoterodine In Filipino Patients With Over Active Bladder

NCT01260311 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 508

Last updated 2014-09-11

Study results available
· View outcomes & findings →

Summary

This is an observational study and will determine the safety profile of fesoterodine in Filipino patients prescribed the drug. This is in compliance with the requirements of the Philippine Food and Drug Administration.

Conditions

  • Over Active Bladder

Interventions

DRUG

Fesoterodine

Any dose of Fesoterodine

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2013-10-31
Completion
2013-10-31

Countries

  • Philippines

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01260311 on ClinicalTrials.gov